1. Duration of obesity exposure between ages 10 and 40 years and its relationship with cardiometabolic disease risk factors: A cohort study
- Author
-
Norris, Tom, Cole, Tim J., Bann, David, Hamer, Mark, Hardy, Rebecca, Li, Leah, Ong, Ken K., Ploubidis, George B., Viner, Russell, and Johnson, William
- Subjects
Obesity -- Complications and side effects -- Demographic aspects ,Metabolic diseases -- Risk factors -- Demographic aspects ,Cardiovascular diseases -- Risk factors -- Demographic aspects ,Biological sciences - Abstract
Background Individuals with obesity do not represent a homogeneous group in terms of cardiometabolic risk. Using 3 nationally representative British birth cohorts, we investigated whether the duration of obesity was related to heterogeneity in cardiometabolic risk. Methods and findings We used harmonised body mass index (BMI) and cardiometabolic disease risk factor data from 20,746 participants (49.1% male and 97.2% white British) enrolled in 3 British birth cohort studies: the 1946 National Survey of Health and Development (NSHD), the 1958 National Child Development Study (NCDS), and the 1970 British Cohort Study (BCS70). Within each cohort, individual life course BMI trajectories were created between 10 and 40 years of age, and from these, age of obesity onset, duration spent obese (range 0 to 30 years), and cumulative obesity severity were derived. Obesity duration was examined in relation to a number of cardiometabolic disease risk factors collected in mid-adulthood: systolic (SBP) and diastolic blood pressure (DBP), high-density-lipoprotein cholesterol (HDL-C), and glycated haemoglobin (HbA1c). A greater obesity duration was associated with worse values for all cardiometabolic disease risk factors. The strongest association with obesity duration was for HbA1c: HbA1c levels in those with obesity for Conclusions Given that the obesity epidemic is characterised by a much earlier onset of obesity and consequently a greater lifetime exposure, our findings suggest that health policy recommendations aimed at preventing early obesity onset, and therefore reducing lifetime exposure, may help reduce the risk of diabetes, independently of obesity severity. However, to test the robustness of our observed associations, triangulation of evidence from different epidemiological approaches (e.g., mendelian randomization and negative control studies) should be obtained., Author(s): Tom Norris 1,*, Tim J. Cole 2, David Bann 3, Mark Hamer 4, Rebecca Hardy 5, Leah Li 2, Ken K. Ong 6, George B. Ploubidis 3, Russell Viner [...]
- Published
- 2020
- Full Text
- View/download PDF